These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21021618)

  • 1. Changes in blood coagulation following coronary thrombosis measured by the heparin retarded clotting test (Waugh and Ruddick test).
    OGURA JH; FETTER NR
    Proc Annu Meet Cent Soc Clin Res U S; 1945; 18():47. PubMed ID: 21021618
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in blood coagulation following coronary thrombosis measured by the heparin retarded clotting test (Waugh and Ruddick test).
    OGURA JH; FETTER NR
    J Clin Invest; 1946 Jul; 25(4):586-96. PubMed ID: 21001633
    [No Abstract]   [Full Text] [Related]  

  • 3. CHANGES IN BLOOD COAGULATION FOLLOWING CORONARY THROMBOSIS MEASURED BY THE HEPARIN RETARDED CLOTTING TEST (WAUGH AND RUDDICK TEST).
    Ogura JH; Fetter NR; Blankenhorn MA; Glueck HI
    J Clin Invest; 1946 Jul; 25(4):586-96. PubMed ID: 16695351
    [No Abstract]   [Full Text] [Related]  

  • 4. [Waugh and Ruddick test; graphic recording of the results of the test; significance and limitations of its clinical use].
    RUOL A; DAL PALU C; RECHICHI A
    Acta Med Patav; 1954; 14(4):657-70. PubMed ID: 14375789
    [No Abstract]   [Full Text] [Related]  

  • 5. An improved plasma recalcified clotting test and its modification as a simple rapid heparin retarded clotting test.
    EASTHAM RD
    J Clin Pathol; 1962 Jan; 15(1):86-7. PubMed ID: 13888970
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in the coagulability of the blood after radiation therapy; the results of studies using the modified Waugh-Ruddick test for increased coagulability.
    SILVERMAN SB
    Am J Roentgenol Radium Ther; 1949 Oct; 62(4):541-6. PubMed ID: 18143149
    [No Abstract]   [Full Text] [Related]  

  • 7. [CHANGES IN BLOOD COAGULATION IN ISCHEMIC CORONARY STATES DETERMINED BY THE HEPARIN TOLERANCE TEST].
    SVEHLA C; SVORCIK C; SLIZ K; SPANKOVA H; MLEJNKOVA M; BAMBASOVA Z
    Cas Lek Cesk; 1964 May; 103():597-600. PubMed ID: 14167009
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE INTERPLAY OF COAGULATION-DECOAGULATION IN THE PATHOGENESIS OF THROMBOTIC DISEASE. III. HYPERCOAGULABILITY AS A PRECEDING STATE OR AS A REACTIVE SITUATION TO THROMBOSIS].
    SANCHEZFAYOS J; OUTEIRINO J; PANIAGUA G; CALABUIG MT
    Rev Clin Esp; 1964 May; 93():157-61. PubMed ID: 14159731
    [No Abstract]   [Full Text] [Related]  

  • 9. [TREATMENT OF ANGINA PECTORIS AND PREVENTION OF CORONARY THROMBOSIS WITH VALOHEPAR].
    LIUBOVICH VI
    Kardiologiia; 1964; 4():57-61. PubMed ID: 14152592
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-thormbin III and heparin clotting times in thrombosis and atherosclerosis.
    O'Brien JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):116-23. PubMed ID: 4454034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EXOGENOUS HEPARIN AND THE HEPARIN CO-FACTOR. EXPERIMENTAL AND CLINICAL STUDIES.
    OLSSON P
    Acta Chir Scand Suppl; 1963; 18():SUPPL319:1-37. PubMed ID: 14085709
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood coagulation in leucemia and polycythemia; value of the heparin clotting time and clot retraction rate.
    ROSENTHAL RL
    J Lab Clin Med; 1949 Oct; 34(10):1321-35. PubMed ID: 18143596
    [No Abstract]   [Full Text] [Related]  

  • 13. EFFECT OF CHANGES IN BLOOD COAGULABILITY ON THE ADHESIVE POWER OF PLATELETS.
    ZUBAIROV DM; DERYANINA GI
    Fed Proc Transl Suppl; 1963; 22():1081-2. PubMed ID: 14079305
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the sensitivity of an in vitro high frequency ultrasound device to monitor the coagulation process: study of the effects of heparin treatment in a murine model.
    Callé R; Rochefort GY; Desbuards N; Plag C; Antier D; Ossant F
    Ultrasound Med Biol; 2010 Feb; 36(2):295-305. PubMed ID: 20045589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aureomycin on heparin concentration and clotting time of human blood.
    WAISBREN BA; GLICK D
    J Lab Clin Med; 1950 Dec; 36(6):1001. PubMed ID: 14795098
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of heparin on three whole blood activated clotting tests and thrombin time.
    Uden DL; Seay RE; Kriesmer PJ; Cipolle RJ; Payne NR
    ASAIO Trans; 1991; 37(2):88-91. PubMed ID: 1854557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aureomycin on heparin concentration and clotting time of human blood.
    WAISBREN BA; GLICK D
    Proc Soc Exp Biol Med; 1950 Nov; 75(2):476-7. PubMed ID: 14808297
    [No Abstract]   [Full Text] [Related]  

  • 18. Heparin-retarded clotting time in a clinical series.
    HEIKINHEIMO R
    Ann Med Intern Fenn; 1962; 51():161-7. PubMed ID: 13953366
    [No Abstract]   [Full Text] [Related]  

  • 19. A heparin-retarded plasma clotting test.
    POLLER L
    Angiology; 1954 Feb; 5(1):21-6. PubMed ID: 13124814
    [No Abstract]   [Full Text] [Related]  

  • 20. A simple apparatus for the determination of blood clotting-times and its application to the assay of heparin.
    BRYCE DM
    J Pharm Pharmacol; 1952 Nov; 4(11):980-4. PubMed ID: 13000674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.